Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report

Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report

ABSTRACT: Objective: Adrenocortical carcinoma (ACC) is a rare disease often associated with hormonal hypersecretion. Hypercortisolism is the most common endocrine syndrome associated with ACC. Abiraterone acetate is a selective and irreversible inhibitor of cytochrome P450 17A1 that is currently use...

Full description

Bibliographic Details
Main Authors: Mélanie Claps, MD, Barbara Lazzari, MD, Salvatore. Grisanti, MD, Vittorio Ferrari, MD, Massimo Terzolo, MD, Sandra Sigala, MD, Sara Vezzoli, MD, Maurizio Memo, MD, Maurizio Castellano, MD, Alfredo Berruti, MD
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520305599

Internet

http://www.sciencedirect.com/science/article/pii/S2376060520305599

Similar Items